Biomarkers in the blood could be used for the early detection of colorectal cancer, lung cancer and ovarian cancer. A new study from Uppsala University shows that the performance of such biomarkers is comparable to or better than established tests and could be developed for clinical use.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗